Bone Marrow Research and the resultant necrosis have masked the subtle potential beneﬁts of increasing tolerance to ischemia. In conclusion, our data did not support the hypothesis of HBO therapy as an eﬀective sole immunosuppressant agent. Perhaps, HBO therapy may be immunosuppressant if combined with other immunosuppressant agents rather than a sole agent. Further research testing diﬀerent combinations of immunosuppressant agents plus HBO is warranted. References [1] E. V. Granowitz, E. J. Skulsky, R. M. Benson et al., “Expo- sure to increased pressure or hyperbaric oxygen suppresses interferon-γ secretion in whole blood cultures of healthy humans,” Undersea and Hyperbaric Medicine, vol. 29, no. 3, pp. 216–225, 2002. [2] R. M. Benson, L. M. Minter, B. A. Osborne, and E. V. Granowitz, “Hyperbaric oxygen inhibits stimulus-induced proinﬂammatory cytokine synthesis by human blood-derived monocyte-macrophages,” Clinical and Experimental Immunol- ogy, vol. 134, no. 1, pp. 57–62, 2003. [3] N. Bitterman, H. Bitterman, A. Kinarty, Y. Melamed, and N. Lahat, “Eﬀect of a single exposure to hyperbaric oxygen on blood mononuclear cells in human subjects,” Undersea & Hyperbaric Medicine, vol. 20, no. 3, pp. 197–204, 1993. [4] M. A. Gadd, D. S. McClellan, T. S. Neuman, and J. F. Hans- brough, “Eﬀect of hyperbaric oxygen on murine neutrophil and T-lymphocyte functions,” Critical Care Medicine, vol. 18, no. 9, pp. 974–979, 1990. [5] W. D. Won, H. C. Ross, and E. F. Deig, “Inﬂuence of cold or hyperbaric helium oxygen environments on mouse response to a respiratory viral infection,” Aviation Space and Environmental Medicine, vol. 47, no. 7, pp. 704–707, 1976. [6] W. D. Won and H. C. Ross, “Catecholamine and phagocytic responses in infected mice exposed to hyperbaric helium oxygen atmospheres,” Aviation Space and Environmental Medicine, vol. 46, no. 2, pp. 191–193, 1975. [7] B. B. Jacobs, C. A. Thuning, M. R. Sacksteder, and J. Warren, “Extended skin allograft survival in mice during prolonged exposure to hyperbaric oxygen,” Transplantation, vol. 28, no. 1, pp. 70–72, 1979. [8] D. Erdmann, A. C. Roth, J. Hussmann et al., “Skin allograft rejection and hyperbaric oxygen treatment in immune- histoincompatible mice,” Undersea & Hyperbaric Medicine, vol. 22, no. 4, pp. 395–399, 1995. [9] D. Erdmann, A. C. Roth, J. Hussmann et al., “Hyperbaric oxygen and cyclosporine as a combined treatment regimen to prevent skin allograft rejection in immunohistoincompatible mice,” Annals of Plastic Surgery, vol. 36, no. 3, pp. 304–308, 1996. [10] I. Brenner, R. J. Shephard, and P. N. Shek, “Immune function in hyperbaric environments, diving, and decompression,” Undersea and Hyperbaric Medicine, vol. 26, no. 1, pp. 27–36, 1999. [11] A. Ersson, M. Walles, K. Ohlsson, and A. Ekholm, “Chronic hyperbaric exposure activates proinﬂammatory mediators in humans,” Journal of Applied Physiology, vol. 92, no. 6, pp. 2375–2380, 2002. [12] C. M. Muth and E. S. Shank, “Gas embolism,” New England Journal of Medicine, vol. 342, no. 7, pp. 476–482, 2000. [13] R. M. Leach, P. J. Rees, and P. Wilmshurst, “Hyperbaric oxygen therapy,” British Medical Journal, vol. 317, no. 7166, pp. 1140– 1143, 1998. 3 [14] S. Enoch, J. E. Grey, and K. G. Harding, “ABC of wound healing. Non-surgical and drug treatments,” British Medical Journal, vol. 332, pp. 900–903, 2006. [15] A. L. Gill and C. N. A. Bell, “Hyperbaric oxygen: its uses, mechanisms of action and outcomes,” QJM, vol. 97, no. 7, pp. 385–395, 2004. [16] E. Calzia, S. O¨ter, C.-M. Muth, and P. Radermacher, “Evolving career of hyperbaric oxygen in sepsis: from augmentation of oxygen delivery to the modulation of the immune response,” Critical Care Medicine, vol. 34, no. 10, pp. 2693–2695, 2006. [17] S. O¨ ter, P. Radermacher, and M. Matejovic, “Can (hyperbaric) oxygen turn oﬀ the motor of multiorgan dysfunction?” Intensive Care Medicine, vol. 32, no. 11, pp. 1694–1696, 2006. [18] C.-M. Muth, P. Radermacher, and S. Cuzzocrea, “Hyperbaric oxygen and sepsis: time to recognize,” Intensive Care Medicine, vol. 31, no. 9, pp. 1150–1152, 2005. [19] S. Hadidi, Z. Chen, J. Phillips, K. Yu, and R. M. Gorczynski, “Antisense deoxyoligonucleotides or antibodies to murine MD-1 inhibit rejection of allogeneic and xenogeneic skin grafts in C3H mice,” Transplantation, vol. 73, no. 11, pp. 1771– 1779, 2002. [20] B. B. Jacobs, C. A. Thuning, M. R. Sacksteder, and J. Warren, “Extended skin allograft survival in mice during prolonged exposure to hyperbaric oxygen,” Transplantation, vol. 28, no. 1, pp. 70–72, 1979. [21] D. Erdmann, A. C. Roth, J. Hussmann et al., “Skin allograft rejection and hyperbaric oxygen treatment in immune- histoincompatible mice,” Undersea & Hyperbaric Medicine., vol. 22, no. 4, pp. 395–399, 1995. [22] D. Erdmann, A. C. Roth, J. Hussmann et al., “Hyperbaric oxygen and cyclosporine as a combined treatment regimen to prevent skin allograft rejection in immunohistoincompatible mice,” Annals of Plastic Surgery, vol. 36, no. 3, pp. 304–308, 1996. [23] W. A. Zamboni, A. C. Roth, R. C. Russell, and E. C. Smoot, “The eﬀect of hyperbaric oxygen on reperfusion of ischemic axial skin ﬂaps: a laser Doppler analysis,” Annals of Plastic Surgery, vol. 28, no. 4, pp. 339–341, 1992. [24] S. Bayati, R. C. Russell, and A. C. Roth, “Stimulation of angiogenesis to improve the viability of prefabricated ﬂaps,” Plastic and Reconstructive Surgery, vol. 101, no. 5, pp. 1290– 1295, 1998. [25] G. Renner, S. D. McClane, E. Early, P. Bell, and B. Shaw, “Enhancement of auricular composite graft survival with hyperbaric oxygen therapy,” Archives of Facial Plastic Surgery, vol. 4, no. 2, pp. 102–104, 2002. [26] L. S. Nichter, D. T. Morwood, G. S. Williams, and R. J. Spence, “Expanding the limits of composite grafting: a case report of successful nose replantation assisted by hyperbaric oxygen therapy,” Plastic and Reconstructive Surgery, vol. 87, no. 2, pp. 337–340, 1991. [27] J. H. Rapley, W. T. Lawrence, and P. D. Witt, “Composite grafting and hyperbaric oxygen therapy in pediatric nasal tip reconstruction after avulsive dog-bite injury,” Annals of Plastic Surgery, vol. 46, no. 4, pp. 434–438, 2001.